News Feed
ARIA funding
We’re proud to share that Relatix Bio has applied for funding from the UK’s Advanced Research and Invention Agency (ARIA) under their Trust Everything, Everywhere programme. This initiative explores how trust can be built across the digital and physical worlds,…
Relatix Bio’s Vision for a Better Tomorrow
This paragraph serves as an introduction to your blog post. Begin by discussing the primary theme or topic that you plan to cover, ensuring it captures the reader’s interest from the very first sentence.…
Empathic Disorders: From Diagnosis to Care
This paragraph serves as an introduction to your blog post. Begin by discussing the primary theme or topic that you plan to cover, ensuring it captures the reader’s interest from the very first sentence.…
News
55 results
Internet addiction in adolescents with suicidal ideation: the role of self-esteem and school connectedness
BackgroundInternet addiction (IA) has become a growing concern, particularly among adolescents, due to its adverse effects on mental health, physical well-being, and future development. Adolescents with suicidal ideation (SI) are particularly vulnerable to IA, which may be associated with a…
The Role of Disulfide Bonds in the GluN1 Subunit in the Early Trafficking and Functional Properties of GluN1/GluN2 and GluN1/GluN3 NMDA Receptors
N-Methyl-d-aspartate receptors (NMDARs) are ionotropic glutamate receptors essential for excitatory neurotransmission. Previous studies proposed the existence of four disulfide bonds in the GluN1 subunit; however, their role in NMDAR trafficking remains unclear. Our study first confirmed the existence of four…
Closing the Gap in Autism Genetics: Population-Specific Variants and the Imperative for Global Inclusion
Autism spectrum disorder (ASD) is a highly heritable neurodevelopmental condition with an exceptionally complex and heterogeneous genetic architecture, encompassing both polygenic common variants and rare, high-impact variants. Over the past decade, large-scale sequencing studies in Europe and North America have…
World Mental Health Day Statement
Ottawa – October 10, 2025 As someone who has worked in countries affected by conflict and humanitarian crises, I’ve learned that physical displacement is only part of the story. The mental and emotional toll defines the other half of that…
Canada Gets its First National Guidance on AI for Mental and Substance Use Health
Ottawa (ONTARIO) – In a first-of-its-kind initiative, national guidance for using artificial intelligence (AI) in the mental and substance use health field is being developed through a partnership between the Canadian Centre on Substance Use and Addiction (CCSA) and the…
Beyond Survival: Addressing the Mental Health Crisis Among the World’s Displaced
By Karla Thorpe, Vice President, Programs and Priorities, Mental Health Commission of Canada. The statistics are staggering, but they represent real human lives: 117 million people worldwide have been forcibly displaced from their homes due to war, famine, and other…
Hertfordshire Community NHS Trust to roll out AI-scribing
Hertfordshire Community NHS Trust is rolling out ambient voice technology following a pilot in community and mental health services.
Development of the Healthy Women Intervention to Increase Women’s Engagement in Medication Treatment for Opioid Use Disorder: Mixed Methods, User-Centered Design Approach
Background: Rates of opioid use disorder (OUD) have increased among women over the past 2 decades. Medication treatment for opioid use disorder (MOUD) is effective but underused. Gender-specific treatments for women have been associated with improved substance use outcomes. However,…
Help-Seeking in the Age of AI: Cross-Sectional Survey of the Use and Perceptions of AI-Based Mental Health Support Among US Adults
Background: Anecdotal evidence suggests that an increasing number of people are turning to generative artificial intelligence (GenAI) tools or artificial intelligence (AI)-assisted chatbots to discuss and manage mental health concerns. However, systematic data on the use and perception of such…
Mass Media Narratives of Psychiatric Adverse Events Associated With Generative AI Chatbots: Rapid Scoping Review
Background: Generative artificial intelligence (AI) chatbots have rapidly entered public use, including in contexts involving emotional support and mental health–related interactions. Although these systems are increasingly accessible, concerns have emerged regarding potential adverse psychiatric outcomes reported in public discourse, including…
The Performance of Wearable Device–Based Artificial Intelligence in Detecting Depression: Systematic Review and Meta-Analysis
Background: In recent years, advances in wearable sensor technology and artificial intelligence (AI) have provided new possibilities for detecting and monitoring depression. Objective: This study systematically reviewed and meta-analyzed the diagnostic and predictive performance of wearable device–based AI models for…
Virtual Reality Implementation in Mental Health Care Is a Marathon, Not a Sprint: Qualitative Longitudinal Study of a Virtual Reality Training Program
Background: Despite the potential of virtual reality (VR) for treatment and assessment in mental health care, its practical implementation remains limited. Much implementation research explores barriers and facilitators; fewer studies actually evaluate targeted implementation strategies and track how their effects…
[Comment] Lived experience perspectives on the development of a Psychosis Metabolic Risk Calculator (PsyMetRiC)
In this issue of The Lancet Psychiatry, Benjamin Perry and colleagues1 present a collaboratively developed, refined, and externally validated risk prediction tool (the Psychosis Metabolic Risk Calculator [PsyMetRiC]) that is clinically available, and that can separately predict the risk of…
ARIA funding
We’re proud to share that Relatix Bio has applied for funding from the UK’s Advanced Research and Invention Agency (ARIA) under their Trust Everything, Everywhere programme. This initiative explores how trust can be built across the digital and physical worlds, and we believe this conversation must…
PSYCHOPATHY.COMP Program Among Male Prison Inmates With Psychopathy
Conditions: Antisocial Personality Disorder (ASPD) Interventions: Behavioral: PSYCHOPATHY.COMP; Other: Treatment as Usual (TAU) Sponsors: University of Coimbra; European Regional Development Fund; Portuguese National Funding Agency for Science, Research and Technology (FCT) Not yet recruiting
Implementing Action-Based Cognitive Remediation for Transdiagnostic Cognitive Difficulties in a Tertiary Mental Health Hospital
Conditions: Psychiatric Disorders; Depression - Major Depressive Disorder; Schizophrenia and Other Psychotic Disorders; Anxiety and Mood Disorders; Bipolar and Related Disorders; PTSD - Post Traumatic Stress Disorder; Autism Spectrum Disorder Interventions: Behavioral: Action-Based Cognitive Remediation Sponsors: The Royal Ottawa Mental…
Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial for Children With Autism Spectrum Disorder
Conditions: Autism Spectrum Disorder Interventions: Behavioral: The Korean version of PEERS® for Preschoolers (PEERS®-PS-K) Sponsors: Seoul National University Bundang Hospital; Kyung Hee University Hospital; Seoul St. Mary's Hospital Active, not recruiting
Virtual Reality-Based Self-Modeling Intervention for Children With Autism Spectrum Disorder
Conditions: Autism Spectrum Disorder Interventions: Behavioral: Virtual Reality Self-Modeling Training; Behavioral: Conventional Behavioral Rehabilitation Sponsors: Inonu University; The Scientific and Technological Research Council of Turkey Enrolling by invitation
Improving Caregiver Engagement in Early Interventions
Conditions: Autism Interventions: Behavioral: FANS-EI; Behavioral: Early Intervention Sponsors: University of California, Davis; National Institute of Mental Health (NIMH) Not yet recruiting
ASD Wearables Feasibility Study
Conditions: Autism Spectrum Disorder; Wearable Device Feasibility Interventions: Device: 14-Day Device Monitoring Sponsors: Rady Pediatric Genomics & Systems Medicine Institute; Rady Children's Hospital, San Diego; University of California, San Diego Completed